Risk factors associated with early mortality in patients with multiple myeloma who were treated upfront with a novel agents containing regimen

BACKGROUND: Although the introduction of novel agents improved the survival outcomes in patients with multiple myeloma (MM), some patients died within one year (early mortality, EM) following diagnosis. In this study, we evaluated the EM rate, and investigated the risk factors associated with EM in...

Descripción completa

Detalles Bibliográficos
Autores principales: Jung, Sung-Hoon, Cho, Min-Seok, Kim, Hee Kyung, Kim, Seok Jin, Kim, Kihyun, Cheong, June-Won, Kim, Soo-Jeoong, Kim, Jin Seok, Ahn, Jae-Sook, Kim, Yeo-Kyeoung, Yang, Deok-Hwan, Kim, Hyeoung-Joon, Lee, Je-Jung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977683/
https://www.ncbi.nlm.nih.gov/pubmed/27501959
http://dx.doi.org/10.1186/s12885-016-2645-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4977683/
https://www.ncbi.nlm.nih.gov/pubmed/27501959
http://dx.doi.org/10.1186/s12885-016-2645-y

Ejemplares similares